One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India.
Médecins Sans Frontières, New Delhi, India.
Sakib
S
Burza
Emara
E
Nabi
Raman
R
Mahajan
Gaurab
G
Mitra
María Angeles
MA
Lima
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012008:Recurrence; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine